1. A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia Schimmer, Aaron D.; Raza, Azra; Carter, Thomas H.; Claxton, David; Erba, Harry; DeAngelo, Daniel J.; Tallman, Martin S.; Goard, Carolyn; Borthakur, Gautam 2014 Articles Cancer--TreatmentAcute myeloid leukemiaNeutrophilsOncologyMedicine
2. Bridging the Gap Between Our Understanding of AML Pathogenesis and the Development of Targeted Therapies Tavakkoli, Montreh 2014 Theses Leukemia--TreatmentCarcinogenesisAcute myeloid leukemiaOncologyEpidemiology
3. Targeting T-cells to Acute Myeloid Leukemia with a Novel Bispecific Antibody Format Burke, Alan Austin 2022 Theses PharmacologyAcute myeloid leukemiaAcute leukemia--TreatmentT cells--Therapeutic usePharmacokineticsCell-mediated cytotoxicity
4. The spectrum of myelodysplastic syndromes post-solid organ transplantation: A single institutional experience Menes, M.; Vakiani, E.; Keller, C.E.; Ho, E. K.; Colovai, A.; Nichols, G.; Diuguid, David L.; Mears, John Gregory; Vundavalli, Murty V.; Alobeid, Bachir; Bhagat, Govind 2007 Articles Acute myeloid leukemiaMyelodysplastic syndromesTransplantation of organs, tissues, etc.ImmunosuppressionCytogenetics